Skip to content
Search

Latest Stories

Reform Party UK to offer tax incentives for new pharmacies amid declining NHS outcomes

Reform Party UK to offer tax incentives for new pharmacies amid declining NHS outcomes
Pharmacies on the election agenda as the Reform Party UK proposes a ‘Pharmacy First, GP Second, A&E Last’ strategy ahead of elections on July 4

In a bid to revolutionise healthcare in the UK, the Reform Party has announced ambitious plans to offer tax incentives to pharmacies.

This move comes despite record extra funding in recent years, which has failed to halt a decline in NHS healthcare outcomes.


The party argues that while healthcare remains free at the point of delivery, significant reforms are essential to enhance results and eliminate waiting lists.

Central to the Reform Party's strategy is a set of critical reforms aimed at addressing NHS challenges within the first 100 days.

The implementation of tax breaks for pharmacies is intended to enhance accessibility and alleviate pressure on NHS resources.

The initiative seeks to encourage the establishment of new pharmacies and expand existing ones, thereby improving healthcare delivery at the community level.

To address emergency healthcare needs, the Reform Party proposes a ‘Pharmacy First, GP Second, A&E Last’ strategy, supported by tax incentives for new pharmacies and those expanding their workforce to alleviate A&E pressure.

Addressing the inefficient model of healthcare, Richard Tice, the party's leader said:

"We all know that taxes have gone up to record levels and yet the quality of outcomes for public services has declined. That can only mean that we are spending money badly."

Highlighting the waste of investment in public services, particularly NHS, he said, "You've got to cut out the waste from the back office and invest in the front office."

The NHS pledge also includes the proposal to end doctor and nurse shortages by exempting all frontline NHS and social care staff from basic rate tax for three years.

This measure is intended to retain current staff and entice those who have left to return.

Additionally, the party plans to end training caps for all UK medical students and proposes writing off student fees pro rata over ten years of NHS service for doctors, nurses, and medical staff.

Further enhancing healthcare capacity, the party aims to leverage independent and not-for-profit health services, both within the UK and overseas.

To stimulate private healthcare growth and reduce pressure on the NHS, the Reform Party is also proposing a 20 per cent tax relief on all private healthcare and insurance.

This initiative is expected to enhance care standards, expedite treatment, and foster competition, thereby reducing overall costs.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less